{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:37:14Z","timestamp":1790743034085,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.ophtha.2012.03.017","type":"journal-article","created":{"date-parts":[[2012,5,18]],"date-time":"2012-05-18T02:51:27Z","timestamp":1337309487000},"page":"e43-e50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Immunomodulatory Effect of the Topical Ophthalmic Janus Kinase Inhibitor Tofacitinib (CP-690,550) in Patients with Dry Eye Disease"],"prefix":"10.1016","volume":"119","clinical-trial-number":[{"clinical-trial-number":"nct00784719","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Jing-Feng","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolla","family":"Yafawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"McDowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay D.","family":"Rittenhouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Sace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiao Hui (Melissa)","family":"Liew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott R.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eve H.","family":"Pickering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2012.03.017_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1542-0124(12)70081-2","article-title":"Report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop","volume":"5","year":"2007","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ophtha.2012.03.017_bib2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/mi.2009.21","article-title":"Role of Th17 cells in the immunopathogenesis of dry eye disease","volume":"2","author":"Chauhan","year":"2009","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.ophtha.2012.03.017_bib3","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/mi.2010.26","article-title":"Autoimmunity at the ocular surface: pathogenesis and regulation","volume":"3","author":"Stern","year":"2010","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.ophtha.2012.03.017_bib4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ajo.2008.08.032","article-title":"Tear cytokine profiles in dysfunctional tear syndrome","volume":"147","author":"Lam","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.03.017_bib5","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/ICO.0b013e3181a16578","article-title":"Analysis of inflammatory cytokines in the tears of dry eye patients","volume":"28","author":"Massingale","year":"2009","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2012.03.017_bib6","first-page":"1356","article-title":"Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes","volume":"41","author":"Brignole","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2012.03.017_bib7","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0161-6420(00)00347-X","article-title":"Flow cytometric analysis of conjunctival epithelium in ocular rosacea and keratoconjunctivitis sicca","volume":"107","author":"Pisella","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2012.03.017_bib8","first-page":"2609","article-title":"Conjunctival T-cell subpopulations in Sjogren's and non-Sjogren's patients with dry eye","volume":"43","author":"Stern","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2012.03.017_bib9","first-page":"90","article-title":"Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A","volume":"42","author":"Brignole","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2012.03.017_bib10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/mi.2009.5","article-title":"IL-17 disrupts corneal barrier following desiccating stress","volume":"2","author":"de Paiva","year":"2009","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.ophtha.2012.03.017_bib11","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.micinf.2009.04.007","article-title":"Signal transduction and Th17 cell differentiation","volume":"11","author":"O'Shea","year":"2009","journal-title":"Microbes Infect"},{"key":"10.1016\/j.ophtha.2012.03.017_bib12","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.4049\/jimmunol.182.3.1247","article-title":"Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression","volume":"182","author":"Chauhan","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.ophtha.2012.03.017_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1476-9255-7-41","article-title":"Anti-inflammatory activity and neutrophil reductions mediated by the JAK1\/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis","volume":"7","author":"Meyer","year":"2010","journal-title":"J Inflamm (Lond) [serial online]"},{"key":"10.1016\/j.ophtha.2012.03.017_bib14","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.4049\/jimmunol.1003668","article-title":"Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550)","volume":"186","author":"Ghoreschi","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.ophtha.2012.03.017_bib15","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/art.33383","article-title":"Phase 2B dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugs","volume":"64","author":"Fleischmann","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ophtha.2012.03.017_bib16","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/art.33419","article-title":"A phase IIB dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone","volume":"64","author":"Kremer","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ophtha.2012.03.017_bib17","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1038\/jid.2009.25","article-title":"Double-blind, placebo-controlled, dose-escalation study to evaluate the pharmacologic effect of CP-690,550 in patients with psoriasis [letter]","volume":"129","author":"Boy","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ophtha.2012.03.017_bib18","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1111\/j.1600-6143.2009.02720.x","article-title":"Calcineurin-inhibitor-free immunosuppression based on the JAK inhibitor CP-690,550: a pilot study in de novo kidney allograft recipients","volume":"9","author":"Busque","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ophtha.2012.03.017_bib19","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.ophtha.2012.01.028","article-title":"Tofacitinib (CP-690,550), a Janus kinase inhibitor for dry eye disease: results from a phase 1\/2 trial","volume":"119","author":"Liew","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2012.03.017_bib20","first-page":"1458","article-title":"Flow cytometry in impression cytology specimens: a new method for evaluation of conjunctival inflammation","volume":"38","author":"Baudouin","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2012.03.017_bib21","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.exer.2003.08.005","article-title":"Flow cytometry in conjunctival impression cytology: a new tool for exploring ocular surface pathologies","volume":"78","author":"Brignole-Baudouin","year":"2004","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ophtha.2012.03.017_bib22","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1749-6632.1986.tb20873.x","article-title":"HLA-D\/DR expression on epithelial cells: the finger on the trigger?","volume":"475","author":"Todd","year":"1986","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ophtha.2012.03.017_bib23","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/(SICI)1097-4652(199710)173:1<110::AID-JCP13>3.0.CO;2-M","article-title":"Interferon-gamma-induced JAK2 and STAT1 signalling in a human salivary gland cell line","volume":"173","author":"Wu","year":"1997","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.ophtha.2012.03.017_bib24","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.4049\/jimmunol.0902819","article-title":"Selective inhibition of JAK1 and JAK2 is efficacious in rodent models of arthritis: preclinical characterization of INCB028050","volume":"184","author":"Fridman","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.ophtha.2012.03.017_bib25","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1002\/art.27536","article-title":"Selective functional inhibition of JAK-3 is sufficient for efficacy in collagen-induced arthritis in mice","volume":"62","author":"Lin","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ophtha.2012.03.017_bib26","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1167\/iovs.08-2476","article-title":"Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome","volume":"50","author":"Chotikavanich","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"Suppl","key":"10.1016\/j.ophtha.2012.03.017_bib27","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/ICO.0b013e31817f4075","article-title":"Epithelial-immune cell interaction in dry eye","volume":"27","author":"Pflugfelder","year":"2008","journal-title":"Cornea"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642012002540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642012002540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:03:25Z","timestamp":1758981805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642012002540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0161642012002540"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2012.03.017","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunomodulatory Effect of the Topical Ophthalmic Janus Kinase Inhibitor Tofacitinib (CP-690,550) in Patients with Dry Eye Disease","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2012.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2012.01.028","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}